Amol Pawar, PhD
Amol is a healthcare finance executive and Head of Corporate Development at Zentalis Pharmaceuticals. Prior to Zentalis Amol was an investment banker at PJT Partners and Deutsche Bank with additional time in equity research covering SMID-cap biotech companies at Stifel. Amol has also spent time at healthcare startup companies in the fields of neurology and high throughput histopathology. He received a PhD in Chemistry from the University of Cambridge as a Gates Scholar as well as an MS (Chemistry) and BA (Biochemistry) at the University of Pennsylvania as a Vagelos Scholar.